ℹ️
🇬🇧
Search
Search for publications relevant for "kardiovaskulární morbidita a mortalita"
kardiovaskulární morbidita a mortalita
Publication
Class
Person
Publication
Programmes
publication
Treatment with statins doesn´t lower the cardiovascular morbidity and mortality - results of AURORA study. Commentary on: NEJM 360,2009,1395-1407
2009 |
First Faculty of Medicine
publication
By inhibition of angiotensin konverting enzyme to beneficial effect on endothelial function and reduction of cardiovascular morbidity and mortality
2003 |
First Faculty of Medicine
publication
Renoprotektivní účinky gliflozinů
2018 |
First Faculty of Medicine
publication
Pharmacotherapy of diabetes: nephrologist's perspective
+1
2017 |
First Faculty of Medicine
publication
Ryödi, E., et al.: Kardiovaskulární morbidita a mortalita u chirurgicky léčené hypertyreózy - celonárodní kohortová studie s dlouhodobým sledováním
2015 |
First Faculty of Medicine
publication
Normalization of hemoglobin doesn´t lower cardiovascular morbidity and mortality in patients with chronic kidney disease
2006 |
First Faculty of Medicine
publication
The Importance of Ambulatory Blood Pressure Monitoring in Hypertension Control of Patients With IgA Nephropathy
2012 |
First Faculty of Medicine
publication
How to approach in suspicion of pheochromocytoma/paraganglioma?
2016 |
First Faculty of Medicine
publication
Kardiovaskulární mortalita u diabetu
2017 |
First Faculty of Medicine
publication
Blockade of the renin-angiotensin-aldosteron system (RAAS) in secondary cardiovascular prevention
2009 |
First Faculty of Medicine
publication
25 years of statins: What happened in the 25 years since the introduction of lovastatin on the market and in clinical practice
2012 |
First Faculty of Medicine
publication
The important players in primary hyperparathyroidism
2014 |
First Faculty of Medicine
publication
News in the treatment of diabetes
2011 |
First Faculty of Medicine
publication
Current trends, news and developments in lipid-lowering therapy in terms of individual groups of pharmaceuticals, their combinations and new technologies
2012 |
Faculty of Medicine in Hradec Králové
publication
Kardiovaskulární bezpečnost empagliflozinu - komentář s diskusí
2016 |
First Faculty of Medicine
publication
EMPA-REG OUTCOME(R) - renální data
2017 |
First Faculty of Medicine
publication
Where is Achilles heel of statins and how to treat it?
2012 |
First Faculty of Medicine
publication
Heart failure treatment quided by plasma brein natriuretic peptide levels
Publication without faculty affiliation
publication
Effect of atorvastatin on non-cholesterol sterol in patients with type 2 diabetes mellitus and cardiovascular disease
2005 |
Publication without faculty affiliation
publication
Effect of atorvastatin on non-cholesterol sterol in patients with type 2 diabetes mellitus and cardiovascular disease
2005 |
Faculty of Medicine in Hradec Králové
publication
Effect of atorvastatin on non-cholesterol sterol in patients with type 2 diabetes mellitus and cardiovascular disease
2005 |
First Faculty of Medicine
publication
Care of patients with hypothyroidism and cardiovascular disease
2019 |
First Faculty of Medicine
publication
Diabetes mellitus and hypertension
2006 |
Second Faculty of Medicine
publication
Antidiabetics and cardiovascular risk
2018 |
First Faculty of Medicine
publication
Nutrition in the prevention and treatment of cardiovascular diseases
2021 |
First Faculty of Medicine
publication
Present and future treatment of hyperlipoproteinemia and dyslipidemia in everyday practice
2017 |
First Faculty of Medicine
publication
Liraglutid; analog GLP-1
2011 |
Second Faculty of Medicine
publication
Pioglitazone safety and efficacy - optimal direct pharmaco-pharmacological intervention of insulin resistance
2017 |
Faculty of Medicine in Hradec Králové
publication
Incretin-based treatment of diabetes and cardiovascular complications
2020 |
First Faculty of Medicine